Condition: Stroke · Chronic Stroke · Hemorrhage Brain · Sponsor: The Methodist Hospital Research Institute
The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.
This description comes directly from the study's public registry record.
Neha Sudarshan, MD · 9082277275 · nsudarshan@houstonmethodist.org
Timea Hodics, MD · 281-381-1728 · tmhodics@houstonmethodist.org
Always discuss trial participation with your own doctor first.
| Houston Methodist Hospital | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06286800